GetTopicDetailResponse(id=bde99e900e0, topicName=阿特珠單抗, introduction=阿特珠單抗, content=null, image=null, comments=1, allHits=2470, url=https://h5.medsci.cn/topic?id=97900, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=70549, tagList=[TagDto(tagId=70549, tagName=阿特珠單抗)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2213225, encodeId=99c622132253c, content=<a href='/topic/show?id=bde99e900e0' target=_blank style='color:#2F92EE;'>#阿特珠單抗#</a> <a href='/topic/show?id=6f3b11622683' target=_blank style='color:#2F92EE;'>#尿路癌#</a> <a href='/topic/show?id=ebc811622e7b' target=_blank style='color:#2F92EE;'>#轉(zhuǎn)移性尿路癌#</a>, objectTitle=Eur Urol Focus：阿特珠單抗治療未分類的局部晚期/轉(zhuǎn)移性尿路癌患者的單臂國際研究 SAUL的最終結(jié)果, objectType=article, longId=832921, objectId=ae7783292127, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240704/1720081627002_92910.jpg, objectUrl=/article/show_article.do?id=ae7783292127, replyNumber=0, likeNumber=72, createdTime=2024-07-04, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ae7783292127, moduleTitle=Eur Urol Focus：阿特珠單抗治療未分類的局部晚期/轉(zhuǎn)移性尿路癌患者的單臂國際研究 SAUL的最終結(jié)果, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ae7783292127)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1233075, encodeId=b5e612330e57c, content=<a href='/topic/show?id=bde99e900e0' target=_blank style='color:#2F92EE;'>#阿特珠單抗#</a>、<a href='/topic/show?id=f38743453f7' target=_blank style='color:#2F92EE;'>#多西他賽#</a>、<a href='/topic/show?id=cbef6022e4c' target=_blank style='color:#2F92EE;'>#曲妥珠單抗#</a>和<a href='/topic/show?id=e56a48488ce' target=_blank style='color:#2F92EE;'>#帕妥珠單抗#</a>新輔助治療ERBB2陽性早期<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>的效果, objectTitle=JAMA Oncol：阿特珠單抗、多西他賽、曲妥珠單抗和帕妥珠單抗新輔助治療ERBB2陽性早期乳腺癌的效果, objectType=article, longId=732001, objectId=e4e7e32001b1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220710/1657426515822_2110107.JPG, objectUrl=/article/show_article.do?id=e4e7e32001b1, replyNumber=0, likeNumber=209, createdTime=2022-07-17, rootId=0, userName=清風徐來2022, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4e7e32001b1, moduleTitle=JAMA Oncol：阿特珠單抗、多西他賽、曲妥珠單抗和帕妥珠單抗新輔助治療ERBB2陽性早期乳腺癌的效果, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e4e7e32001b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
